Travere Therapeutics TVTX
NASDAQ TVTX
$56.93 +0.08 (+0.14%)
At close: Oct 2, 2026 · 4:00 PM EDT

Travere Therapeutics (TVTX) Net Equity Issued and Repurchased (2013 - 2026)

Updated

Travere Therapeutics' Net Equity Issued and Repurchased came in at $27.84 million for Q2 2026, compared with $463,000 a year earlier and up 488.7% from the prior quarter.

Analysis

Travere Therapeutics (TVTX) Net Equity Issued and Repurchased (2013 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Travere Therapeutics reported Net Equity Issued and Repurchased of $62.61 million, down 54.7% year-over-year; for FY2025, it came in at $34.75 million, down 74.2% from FY2024.

  • Net Equity Issued and Repurchased carries a five-year compound annual growth rate of 54.9% (FY2020 to FY2025).
  • Going back by year, Net Equity Issued and Repurchased was $134.74 million in FY2024 (-29.5%), $191.2 million in FY2023, $4.59 million in FY2022 (-97.6%) and $189.28 million in FY2021.
  • The Q2 2026 figure represents the highest quarterly Net Equity Issued and Repurchased since Q4 2024.
  • Year-over-year, Net Equity Issued and Repurchased increased in 1 of the last four quarters, with an average decline of 38.4%.
  • The fastest year-over-year change in Net Equity Issued and Repurchased over five years came in Q2 2022 (growth of 341.1%), and the weakest in Q4 2022 (a decline of 99.9%).
  • Business Quant data shows TVTX's Net Equity Issued and Repurchased at $4.73 million (Q1 2026), $25.95 million (Q4 2025) and $4.09 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn -
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn -
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn -
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 43.00 Mn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 6.00 Mn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn -
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 9.00 Mn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn -
10 Travere Therapeutics 5.35 Bn 4.95 Bn 167.41 Mn 27.84 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 27.84 Mn
Mar 31, 2026 4.73 Mn
Dec 31, 2025 25.95 Mn
Sep 30, 2025 4.09 Mn
Jun 30, 2025 463,000.00
Mar 31, 2025 4.24 Mn
Dec 31, 2024 133.43 Mn
Jun 30, 2024 1.31 Mn
Dec 31, 2023 166.57 Mn
Mar 31, 2023 24.63 Mn
Dec 31, 2022 231,000.00
Sep 30, 2022 2.83 Mn
Jun 30, 2022 1.41 Mn
Mar 31, 2022 122,000.00
Dec 31, 2021 182.60 Mn
Sep 30, 2021 3.61 Mn
Jun 30, 2021 319,000.00
Mar 31, 2021 2.76 Mn
Dec 31, 2020 2.55 Mn
Mar 31, 2020 60,000.00
API Access

Travere Therapeutics Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=TVTX&period=max&api_key=YOUR_API_KEY